A multicenter clinical study evaluating the confirmed complete molecular response rate in imatinib-treated patients with chronic phase chronic myeloid leukemia by using the international scale of real-time quantitative polymerase chain reaction
about
Pharmacogenetics of BCR/ABL Inhibitors in Chronic Myeloid LeukemiaThe effect of BIM deletion polymorphism on intrinsic resistance and clinical outcome of cancer patient with kinase inhibitor therapy.Combination of White Blood Cell Count at Presentation With Molecular Response at 3 Months Better Predicts Deep Molecular Responses to Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Patients.Hepatitis B reactivation in patients receiving targeted therapies.Reduced ABCG2 and increased SLC22A1 mRNA expression are associated with imatinib response in chronic myeloid leukemia.The BCL2L11 deletion polymorphism is not associated with imatinib resistance in chronic myeloid leukemia patients: meta-analysis.Trough concentration and ABCG2 polymorphism are better to predict imatinib response in chronic myeloid leukemia: a meta-analysis.Association of ABCG2 polymorphism with clinical efficacy of imatinib in patients with gastrointestinal stromal tumor.Reply: the BIM deletion polymorphism cannot account for intrinsic TKI resistance of Chinese individuals with chronic myeloid leukemia.
P2860
Q26781539-35B7FF91-909A-49DF-BEEB-2EAA78025BCEQ35740819-A61A7627-2B56-4A16-9700-EB6A4EDC5CD8Q36478229-F0EC3EB4-68AE-4B8B-81FA-B637AE1E7F1CQ39293427-07A54C98-732D-4DF6-A79D-E3EE5D745C4FQ46788822-8BDDD65E-2C5E-4AE0-A3DD-9949142426D9Q47162677-895886A1-95C8-4D9C-AA56-B13FEFB9F3B4Q51251518-9240A2AB-9B59-49CD-BAF0-CE25339070A2Q55070104-8969AD81-26AF-40C4-A3B9-3FD2169CC99CQ55070789-577EED33-F71F-4A51-8A93-3471FE873F79
P2860
A multicenter clinical study evaluating the confirmed complete molecular response rate in imatinib-treated patients with chronic phase chronic myeloid leukemia by using the international scale of real-time quantitative polymerase chain reaction
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A multicenter clinical study e ...... tive polymerase chain reaction
@en
A multicenter clinical study e ...... ive polymerase chain reaction.
@nl
type
label
A multicenter clinical study e ...... tive polymerase chain reaction
@en
A multicenter clinical study e ...... ive polymerase chain reaction.
@nl
prefLabel
A multicenter clinical study e ...... tive polymerase chain reaction
@en
A multicenter clinical study e ...... ive polymerase chain reaction.
@nl
P2093
P2860
P921
P1433
P1476
A multicenter clinical study e ...... tive polymerase chain reaction
@en
P2093
Akira Hirasawa
Atsuko Mugitani
Hidekazu Masuoka
Hirohisa Nakamae
Hisashi Wakita
Jun Kuroki
Kaichi Nishiwaki
Kenichi Sawada
Kuniaki Itoh
P2860
P304
P356
10.3324/HAEMATOL.2013.085167
P577
2013-05-28T00:00:00Z